StockData
Septerna, Inc. logo

Septerna, Inc. (SEPN) stock

SEPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30165% above fair value
$38.61−0.59 (-1.51%)

Close on Nov 20, 2026Market cap $1.80BP/E –Yield –

Septerna gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Septerna

Septerna has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Septerna figures

See a number that looks wrong?